The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 31.80
Ask: 32.90
Change: 0.50 (1.54%)
Spread: 1.10 (3.459%)
Open: 32.00
High: 33.00
Low: 32.00
Prev. Close: 32.50
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cancellation of share options

11 Jun 2019 14:15

RNS Number : 8592B
EKF Diagnostics Holdings PLC
11 June 2019
 

 

EKF Diagnostics Holdings plc

("EKF", the "Company")

 

Cancellation of share options

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that 250,000 share options over ordinary shares of 1 penny each (the "Ordinary Shares") granted to a PDMR of the Company (the "Options") have been cancelled at the election of the option holder in return for the payment of a one-off cash sum.

 

Details of the cancellation of the Options are set out below:

 

PDMR

Role

Number of Options being surrendered

Cash payment (£)

Martyn Lewis

APAC Sales Director & Head of Marketing

250,000

£15,625

 

The cash sum to be paid has been calculated by reference to the closing price of 33.5p, being the price at the time the offer was made to the option holder. There are no more share options held by Martyn Lewis following this cancellation.

 

Following the cancellation of the above, other share options remain over a total of 950,000 Ordinary Shares. These options are exercisable at various prices of between 20p and 37.625p and carry expiry dates ranging between 7 July 2023 and 6 April 2025.

 

 

For further information:

 

EKF Diagnostics Holdings plc www.ekfdiagnostics.com Tel: 029 2071 0570

 

Christopher Mills, Non-Executive Chairman

Julian Baines, CEO 

 

 

Richard Evans, FD & COO

 

 

 

N+1 Singer (Nomad and Broker)

 

Tel: 020 7496 3000

 

Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance)

Tom Salveson (Corporate Broking)

 

 

 

 

Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com

 

Paul McManus

Mob: 07980 541 893

 

Lianne Cawthorne

Mob: 07584 391 303

 

     

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Martyn Lewis - APAC Sales Director & Head of Marketing

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above for position - classified as a PDMR of EKF

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

EKF Diagnostics Holdings plc

b)

 

LEI

213800DXTF3EAUK1AR05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument 

In each case, the grant of Options over Ordinary Shares

b)

Identification code 

GB0031509804

c)

 

Nature of the transaction 

Cancellation of Options over Ordinary Shares 

d)

 

Price(s) and volume(s)

Price - n/a

Volume

Martyn Lewis - 250,000 Options

 

d)

 

Aggregated information 

- Aggregated volume

- Price

 

250,000

N/A

e)

 

Date of the transaction 

11 June 2019

f)

 

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFBMJTMBBBBBL
Date   Source Headline
7th Apr 20207:00 amRNSFinal Results
24th Mar 20207:00 amRNSDetailed trading review including COVID-19 update
20th Mar 20207:00 amRNSInvestor results briefing update
4th Mar 20207:00 amRNSNotice of Results
24th Feb 20201:56 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading update
6th Nov 201912:14 pmRNSTrading update and performance bonuses
10th Sep 20197:00 amRNSHalf-year Report
10th Sep 20197:00 amRNSPreferred Partner Arrangement with Mount Sinai
21st Aug 20197:00 amRNSNotice of Results
8th Aug 20194:40 pmRNSSecond Price Monitoring Extn
8th Aug 20194:35 pmRNSPrice Monitoring Extension
15th Jul 20197:00 amRNSTrading update
11th Jun 20192:15 pmRNSCancellation of share options
7th Jun 20194:30 pmRNSHolding(s) in Company
28th May 20197:00 amRNSDirector/PDMR Shareholding
2nd May 201911:21 amRNSResult of AGM
26th Apr 20196:20 pmRNSAcquisition of further interest in Renalytix AI
25th Apr 20197:00 amRNSPosting of AR & Accounts and Notice of AGM
13th Mar 20197:00 amRNSFinal Results
8th Mar 20197:00 amRNSNotice of Results
20th Feb 20197:00 amRNSUS FDA approval for Quo-Test analyser
22nd Jan 20197:00 amRNSUpdate on McKesson US distribution agreement
21st Jan 20197:00 amRNSClarification re. lock-up restrictions
16th Jan 20197:00 amRNSTrading update
20th Dec 20187:00 amRNSUpdate regarding planned change of NOMAD
19th Dec 20184:56 pmRNSPDMR dealing
7th Dec 20183:15 pmRNSPurchase of own shares and PDMR Dealing
30th Nov 20182:35 pmRNSTotal Voting Rights
22nd Nov 20185:13 pmRNSPurchase of own shares and PDMR Dealing
21st Nov 20182:08 pmRNSPurchase of own shares and PDMR Dealing
20th Nov 20185:18 pmRNSPurchase of own shares and PDMR Dealing
14th Nov 20182:20 pmRNSShare Buy-Back
9th Nov 20181:48 pmRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSRENX Admission to AIM and First Day of Dealings
2nd Nov 20188:00 amRNSSchedule 1 update - Renalytix AI plc
1st Nov 20185:30 pmRNSUpdate regarding AIM admission of RenalytixAI
31st Oct 20186:00 pmRNSResult of RO by RenalytixAI & Fundraising Update
23rd Oct 20182:00 pmRNSSchedule One Update - Renalytix AI plc
23rd Oct 201811:01 amRNSUpdate to distribution timetable
22nd Oct 20185:23 pmRNSApproval of distribution of shares in RenalytixAI
19th Oct 201812:10 pmRNSResult of General Meeting
19th Oct 201811:00 amRNSSchedule One - Renalytix AI plc
12th Oct 20187:00 amRNSInvestor presentation
11th Oct 20186:03 pmRNSLaunch of Restricted Offer by Renalytix AI plc
11th Oct 20185:21 pmRNSFundraising and AIM admission of Renalytix AI plc
11th Oct 20184:01 pmRNSFundraising and AIM admission of Renalytix AI plc
27th Sep 201810:15 amRNSNotice of GM
19th Sep 20187:00 amRNSHalf-year Report
17th Sep 201812:21 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.